SEC
Fundamental Analysis
1 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIXNurix Therapeutics, Inc. | 50.4 | 0 | 40 | 83 | +12.6% | -63.21% | n/a | -110.7% | +32.94% | 0% | 0 | n/a | n/a | ROIC expansion, Net debt reduction2 warnings |
1-1 of 1